Nav1.7-IN-19
Nav1.7-IN-19 is a potent, selective and orally active Nav1.7 inhibitor with an IC50 of 0.49 μM. Nav1.7-IN-19 shows high selectivity for Nav1.7, with selectivities of 312-fold and 662-fold against Nav1.1 and Nav1.5 in the inactivated state. Nav1.7-IN-19 exhibits weak inhibition on hERG potassium channels. Nav1.7-IN-19 exhibits analgesic effect and can be used for the research of neurological disease[1].
Product Specifications
CAS Number
3097995-73-5
UNSPSC
12352005
Target
Potassium Channel; Sodium Channel
Related Pathways
Membrane Transporter/Ion Channel
Field of Research
Neurological Disease
Smiles
NC(C(C1CC1)NCCCC2=C(C=CC(Cl)=C2)OC3=C(C=C(C(F)=C3)S(=O)(NC4=NOC=C4)=O)Br)=O
Molecular Formula
C23H23BrClFN4O5S
Molecular Weight
601.87
References & Citations
[1]Wu R, et al. Design, synthesis, structure-activity relationship (SAR) and analgesic effect studies of novel arylsulfonamides as selective Nav1.7 inhibitors. Eur J Med Chem. 2025 Dec 5;299:118069.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Nav1.7
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680889-500 1x 500 µL
PLAP (Placental Alkaline Phosphatase) (PL8-F6), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040744-100 1x 100 µL
Prolactin Receptor (B6.2 + PRLR742), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741757-100 1x 100 µL
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/1757), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400756-500 1x 500 µL
Neurofilament (H+L) (NF421 + NFL736), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042074-100 1x 100 µL
Prostate Specific Acid Phosphatase (PSAP) (rACPP/1338), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741120-100 1x 100 µL
Ep-CAM / CD326 (EGP40/1120), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details